Peter Black

Dr. Peter Black has a clinical subspecialty interest in bladder cancer. He also maintains a grant-funded translational research program in urothelial carcinoma with a focus on genomic analysis of response to chemotherapy, mechanisms of resistance to chemotherapy, and novel targeted therapies for bladder cancer. One of his main laboratory projects relates to Notch signaling in bladder cancer and how to modulate this pathway for therapeutic purposes.

For an up-to-date list of publications by Dr. Black, please see the Vancouver Prostate Centre website.